Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • Interphase, prophase, metaphase, anaphase, telophase [undo]
  • Omalizumab (IgE antibody)/Salbutamol (SABA) [undo]
  • Start shouting at her to move away and stop disturbing you. [undo]
  • Use only Mendelian probability [undo]
  • LB [undo]
  • Overstaining of the cells [undo]
  • ΑΠΟΤΕΛΕΣΜΑΤΑ ΗΛΕΚΤΡΟΚΑΡΔΙΟΓΡΑΦΗΜΑΤΟΣ [undo]
  • Tampoane de spălare [undo]
  • ΚΥΤΤΑΡΙΚΗ ΔΟΜΗ ΚΑΙ ΛΕΙΤΟΥΡΓΙΑ [undo]
  • Furosemide (loop diuretic) [undo]
  • ΑΠΟΤΕΛΕΣΜΑΤΑ ΕΞΕΤΑΣΕΩΝ ΑΙΜΑΤΟΣ [undo]
  • new node [undo]
  • Προτείνεις να ζητήσουμε χρήματα από την τράπεζα. [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21088
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway